Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIODESIX INCBDSX · Entity 6053 | Chief Accounting Officer | May 08, 2023 | May 11, 2023 |
| EverCommerce Inc.EVCM · Entity 4719 | Chief Financial Officer | September 05, 2026 | September 08, 2026 |
| VAIL RESORTS INCMTN · Entity 3943 | SVP, Controller & CAO | September 28, 2020 | September 30, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIODESIX INC
Report date May 08, 2023 · Filed May 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,288 |
Reported balance
After 2023-05-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-08 · Exercise / conversion · Acquired 5,484 · Balance 42,288 F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2: Includes 9,643 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023. |
| Common StockSEC Table I · non-derivative | Direct | 40,832 |
Reported balance
After 2023-05-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-05-09 · Sale · Disposed 1,456 · Balance 40,832 F3: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F4: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 40,268 |
Reported balance
After 2023-05-10 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2023-05-10 · Sale · Disposed 564 · Balance 40,268 F3: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F5: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 21,193 |
Reported balance
After 2023-05-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-05-08 · Exercise / conversion · Disposed 1,927 · Balance 21,193 F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F6: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,557 |
Reported balance
After 2023-05-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-05-08 · Exercise / conversion · Disposed 3,557 · Balance 3,557 F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. F7: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2: Includes 9,643 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023.
F3: These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs.
F4: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F7: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
EverCommerce Inc.
Report date September 05, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 336,713 |
Ending reported balance
After 2026-09-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-05 · Tax withholding · Disposed 2,606 · Balance 339,513 F1: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 5, 2025. Row 2 · 2026-09-05 · Tax withholding · Disposed 2,800 · Balance 336,713 F2: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 5, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 5, 2025.
F2: Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on March 5, 2026.
VAIL RESORTS INC
Report date September 28, 2020 · Filed September 30, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 609 |
Ending reported balance
After 2020-09-28 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2020-09-28 · Exercise / conversion · Acquired 836 · Balance 1,445 Row 2 · 2020-09-28 · Tax withholding · Disposed 579 · Balance 866 F1: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith. Row 3 · 2020-09-28 · Exercise / conversion · Acquired 2,133 · Balance 2,999 Row 4 · 2020-09-28 · Tax withholding · Disposed 1,681 · Balance 1,318 F1: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith. Row 5 · 2020-09-28 · Sale · Disposed 709 · Balance 609 |
| Share Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $129.64 · Expires 2026-05-01 | Direct | 0 |
Reported balance
After 2020-09-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-09-28 · Exercise / conversion · Disposed 836 · Balance 0 F2: On May 1, 2016, Reporting Person was granted 1,255 Share Appreciation Rights, which vested in three equal annual installments beginning on May 1, 2017. |
| Share Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $160.56 · Expires 2026-09-23 | Direct | 0 |
Reported balance
After 2020-09-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-09-28 · Exercise / conversion · Disposed 2,133 · Balance 0 F3: On September 23, 2016, Reporting Person was granted 3,200 Share Appreciation Rights, which vested in three equal annual installments beginning on September 23, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith.
F2: On May 1, 2016, Reporting Person was granted 1,255 Share Appreciation Rights, which vested in three equal annual installments beginning on May 1, 2017.
F3: On September 23, 2016, Reporting Person was granted 3,200 Share Appreciation Rights, which vested in three equal annual installments beginning on September 23, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 21:16 UTC | BIODESIX INC BDSX · Entity 6053 | GrantStock Options (Right to buy) · Derivative | 114,204 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001140361-23-010028 · form4.xml · derivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,204 Underlying: Common Stock · 114,204 shares Expires 2033-02-28 F1 · derivative.exercise_date: This option vested in full on March 1, 2023. Under the Issuer's 2022 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2022 in the form of a fully-vested option. Read SEC document |
| February 09, 2023 Filed Feb 10, 2023 23:40 UTC | BIODESIX INC BDSX · Entity 6053 | SaleCommon Stock | 2,016 | $1.80 | $3,626.99 |
DisclosureSEC source: 0001140361-23-006075 · form4.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,161 F2 · kind: These shares of Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs. F3 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:40 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionRestricted Stock Units · Derivative | 3,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006075 · form4.xml · derivative · entry 5 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,114 Underlying: Common Stock · 3,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock. F6 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F6 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:40 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionRestricted Stock Units · Derivative | 1,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006075 · form4.xml · derivative · entry 4 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,120 Underlying: Common Stock · 1,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock. F5 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F5 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:40 UTC | BIODESIX INC BDSX · Entity 6053 | GrantRestricted Stock Units · Derivative | 82,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006075 · form4.xml · derivative · entry 3 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,031 Underlying: Common Stock · 82,031 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock. F4 · derivative.exercise_date: These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. F4 · derivative.expiration_date: These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:40 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 5,483 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-006075 · form4.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer's common stock. Read SEC document |
| November 21, 2022 Filed Nov 21, 2022 23:03 UTC | BIODESIX INC BDSX · Entity 6053 | GrantCommon Stock | 8,695 | $1.15 | $9,999.25 |
DisclosureSEC source: 0001140361-22-042600 · form4.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,694 Read SEC document |
| November 10, 2022 Filed Nov 11, 2022 02:02 UTC | BIODESIX INC BDSX · Entity 6053 | SaleCommon Stock | 762 | $1.02 | $775.34 |
DisclosureSEC source: 0001140361-22-041077 · form4.xml · nonDerivative · entry 3 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,999 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F6 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2022 Filed Nov 11, 2022 02:02 UTC | BIODESIX INC BDSX · Entity 6053 | SaleCommon Stock | 963 | $1.04 | $1,003.25 |
DisclosureSEC source: 0001140361-22-041077 · form4.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,761 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2022 Filed Nov 11, 2022 02:02 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionRestricted Stock Units · Derivative | 3,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-041077 · form4.xml · derivative · entry 5 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,670 Underlying: Common Stock · 3,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| November 08, 2022 Filed Nov 11, 2022 02:02 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionRestricted Stock Units · Derivative | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-041077 · form4.xml · derivative · entry 4 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,047 Underlying: Common Stock · 1,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| November 08, 2022 Filed Nov 11, 2022 02:02 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 5,482 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-041077 · form4.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 22:54 UTC | BIODESIX INC BDSX · Entity 6053 | SaleCommon Stock | 1,645 | $2.53 | $4,158.89 |
DisclosureSEC source: 0001140361-22-029136 · form4.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,242 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionRestricted Stock Units · Derivative | 3,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029136 · form4.xml · derivative · entry 4 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,227 Underlying: Common Stock · 3,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionRestricted Stock Units · Derivative | 1,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029136 · form4.xml · derivative · entry 3 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,972 Underlying: Common Stock · 1,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 5,484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-029136 · form4.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| May 10, 2022 Filed May 12, 2022 01:42 UTC | BIODESIX INC BDSX · Entity 6053 | SaleCommon Stock | 1,947 | $1.83 | $3,563.01 |
DisclosureSEC source: 0001140361-22-018735 · form4.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,403 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionRestricted Stock Units · Derivative | 3,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018735 · form4.xml · derivative · entry 4 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,784 Underlying: Common Stock · 3,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionRestricted Stock Units · Derivative | 1,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018735 · form4.xml · derivative · entry 3 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,899 Underlying: Common Stock · 1,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC | BIODESIX INC BDSX · Entity 6053 | Exercise / conversionCommon Stock | 5,484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-018735 · form4.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F6 · balance_after: Includes 1,262 and 2,604 Shares acquired under the BDSX stock purchase plan on August 31, 2021 and February 28, 2022, respectively. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 21:54 UTC | BIODESIX INC BDSX · Entity 6053 | GrantStock Options (Right to buy) · Derivative | 30,887 | $0.00 Strike: $2.29 | $0.00 |
DisclosureSEC source: 0001567619-22-006923 · doc1.xml · derivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,887 Underlying: Common Stock · 30,887 shares Expires 2032-03-09 Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC | BIODESIX INC BDSX · Entity 6053 | GrantRestricted Stock Units · Derivative | 21,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004590 · form4.xml · derivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,341 Underlying: Common Stock · 21,341 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| February 08, 2022 Filed Feb 11, 2022 00:09 UTC | BIODESIX INC BDSX · Entity 6053 | GrantRestricted Stock Units · Derivative | 30,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004590 · form4.xml · derivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,826 Underlying: Common Stock · 30,826 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| January 07, 2021 Filed Jan 12, 2021 00:09 UTC | BIODESIX INC BDSX · Entity 6053 | GrantStock Options (Right to buy) · Derivative | 45,000 | $0.00 Strike: $19.16 | $0.00 |
DisclosureSEC source: 0000905148-21-000049 · form4.xml · derivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2031-01-06 F1 · date: This option vests 40% on December 31, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from December 31, 2022. F1 · kind: This option vests 40% on December 31, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from December 31, 2022. F1 · derivative.exercise_date: This option vests 40% on December 31, 2022, and the remaining 60% in 36 successive, equal monthly installments measured from December 31, 2022. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:11 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionShare Appreciation Right · Derivative | 2,133 | $0.00 Strike: $160.56 | $0.00 |
DisclosureSEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · derivative · entry 7 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,133 shares Expires 2026-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On September 23, 2016, Reporting Person was granted 3,200 Share Appreciation Rights, which vested in three equal annual installments beginning on September 23, 2017. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:11 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionShare Appreciation Right · Derivative | 836 | $0.00 Strike: $129.64 | $0.00 |
DisclosureSEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · derivative · entry 6 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 836 shares Expires 2026-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 1, 2016, Reporting Person was granted 1,255 Share Appreciation Rights, which vested in three equal annual installments beginning on May 1, 2017. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:11 UTC | VAIL RESORTS INC MTN · Entity 3943 | SaleCommon Stock | 709 | $227.68 | $161,425.12 |
DisclosureSEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 5 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609 Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:11 UTC | VAIL RESORTS INC MTN · Entity 3943 | Tax withholdingCommon Stock | 1,681 | $228.94 | $384,848.14 |
DisclosureSEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 4 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,318 F1 · shares: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:11 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionCommon Stock | 2,133 | $160.56 | $342,474.48 |
DisclosureSEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 3 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:11 UTC | VAIL RESORTS INC MTN · Entity 3943 | Tax withholdingCommon Stock | 579 | $228.94 | $132,556.26 |
DisclosureSEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 866 F1 · shares: Shares of common stock were withheld from the issuance of common stock to the Reporting Person upon exercise in order to satisfy the Reporting Person's obligations for payment of the exercise price and withholding and other taxes due in connection therewith. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 20:11 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionCommon Stock | 836 | $129.64 | $108,379.04 |
DisclosureSEC source: 0000812011-20-000094 · wf-form4_160149664839460.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionRestricted Share Unit · Derivative | 92 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · derivative · entry 9 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 92 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On September 27, 2017, Reporting Person was granted 275 RSUs, which vested in three equal annual installments beginning on September 27, 2018. F6 · derivative.expiration_date: On September 27, 2017, Reporting Person was granted 275 RSUs, which vested in three equal annual installments beginning on September 27, 2018. Read SEC document |
| September 27, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionRestricted Share Unit · Derivative | 137 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · derivative · entry 8 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137 Underlying: Common Stock · 137 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019. F5 · derivative.expiration_date: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019. Read SEC document |
| September 27, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Tax withholdingCommon Stock | 40 | $225.26 | $9,010.40 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 6 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609 F3 · shares: 40 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of RSUs in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith. Read SEC document |
| September 27, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionCommon Stock | 137 | $0.00 | $0.00 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 5 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Tax withholdingCommon Stock | 27 | $225.26 | $6,082.02 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 4 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512 F2 · shares: 27 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of RSUs in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith. Read SEC document |
| September 27, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionCommon Stock | 92 | $0.00 | $0.00 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 3 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionRestricted Share Unit · Derivative | 289 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · derivative · entry 7 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578 Underlying: Common Stock · 289 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On September 25, 2019, Reporting Person was granted 867 RSUs, which vest in three equal annual installments beginning on September 25, 2020. F4 · derivative.expiration_date: On September 25, 2019, Reporting Person was granted 867 RSUs, which vest in three equal annual installments beginning on September 25, 2020. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Tax withholdingCommon Stock | 84 | $225.26 | $18,921.84 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447 F1 · shares: 84 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of Restricted Stock Units (RSUs) in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 21:50 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionCommon Stock | 289 | $0.00 | $0.00 |
DisclosureSEC source: 0000812011-20-000082 · wf-form4_160141622625007.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | SaleCommon Stock | 100 | $236.98 | $23,698.00 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 7 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242 Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | SaleCommon Stock | 700 | $235.85 | $165,095.00 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 6 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342 F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.55 to $236.52, inclusive. The Reporting Person undertakes to provide Vail Resorts, Inc., any security holder of Vail Resorts, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | SaleCommon Stock | 98 | $234.50 | $22,981.00 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 5 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042 Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionRestricted Share Unit · Derivative | 138 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · derivative · entry 9 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274 Underlying: Common Stock · 138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019. F3 · derivative.expiration_date: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionRestricted Share Unit · Derivative | 91 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · derivative · entry 8 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92 Underlying: Common Stock · 91 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On September 27, 2017, Reporting Person was granted 275 Restricted Share Units ("RSUs"), which vest in three equal annual installments beginning on September 27, 2018. F1 · derivative.expiration_date: On September 27, 2017, Reporting Person was granted 275 Restricted Share Units ("RSUs"), which vest in three equal annual installments beginning on September 27, 2018. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | Tax withholdingCommon Stock | 40 | $236.98 | $9,479.20 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 4 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,140 F4 · shares: 40 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of RSUs in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionCommon Stock | 138 | $0.00 | $0.00 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 3 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On September 27, 2018, Reporting Person was granted 412 RSUs, which vest in three equal annual installments beginning on September 27, 2019. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | Tax withholdingCommon Stock | 27 | $236.98 | $6,398.46 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042 F2 · shares: 27 shares of common stock were withheld from the issuance of common stock to Reporting Person upon vesting of RSUs in order to satisfy the Reporting Person's obligations for payment of withholding and other taxes due in connection therewith. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 21:58 UTC | VAIL RESORTS INC MTN · Entity 3943 | Exercise / conversionCommon Stock | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0000812011-19-000120 · wf-form4_156996710335688.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On September 27, 2017, Reporting Person was granted 275 Restricted Share Units ("RSUs"), which vest in three equal annual installments beginning on September 27, 2018. Read SEC document |
| September 25, 2019 Filed Sep 27, 2019 21:24 UTC | VAIL RESORTS INC MTN · Entity 3943 | GrantRestricted Share Unit · Derivative | 867 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000812011-19-000104 · wf-form4_156961948034013.xml · derivative · entry 2 Siurek Ryan H · CIK 0001476512 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 867 Underlying: Common Stock · 867 shares Expires not disclosed F2 · derivative.exercise_date: On September 25, 2019, Reporting Person was granted 867 Restricted Share Units, which vest in three equal annual installments beginning on September 25, 2020. F2 · derivative.expiration_date: On September 25, 2019, Reporting Person was granted 867 Restricted Share Units, which vest in three equal annual installments beginning on September 25, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.